Stay updated on Nivolumab in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study page now indicates that recruitment has ended and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Study Plan area is updated to include an Intervention/Treatment label, and the revision note updates to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-13T01:29:27.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s revision label changed from v3.5.4 to v3.5.5, indicating a behind-the-scenes update to the site’s software or layout rather than a change to study content or details.
    Difference
    0.0%
    Check dated 2026-06-05T22:47:29.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4. This indicates a new deployment of the site, typically reflecting minor fixes or updates rather than changes to visible content.
    Difference
    0.0%
    Check dated 2026-05-15T13:57:05.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page’s revision/version indicator for the ClinicalTrials.gov site has been bumped from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:50:03.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:31:34.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Frontend revision updated: v3.5.0 deployed and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T04:51:42.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.